Comparative Characteristics of Tuberculosis and Mycobacteriosis in Two Regions of the Russian Federation: Mari El Republic and Vladimir Region

The objective: to study the regional prevalence of mycobacteriosis and the types of non-tuberculous mycobacteria causing mycobacteriosis in Mari El Republic and Vladimir Region, to conduct a comparative clinical and radiological analysis of mycobacteriosis and tuberculosis.

Subjects and Methods. Cultures of non-tuberculous mycobacteria available in the bank of the bacteriological laboratory of two regions were analyzed: 182 cultures in the Republic of Mari El and 44 cultures in Vladimir Region. Medical records and X-ray archives of patients who were found to be positive for non-tuberculous mycobacteria were retrospectively studied.

Results. The incidence of mycobacteriosis in Vladimir Region and Mari El Republic made 1.5 and 4.3 cases per 100,000 population, respectively. Cultures of non-tuberculous mycobacteria that caused mycobacteriosis belonged to diverse species, and M.avium-complex was the most common (76% of cases). There were no statistically significant differences in the location and extent of lesions in patients with mycobacteriosis and tuberculosis (p > 0.05). The frequency of positive results of Mantoux test with 2TU was comparable Positive results of TRA test were found significantly more often among patients with tuberculosis versus patients with mycobacteriosis (15/19 (78.9%) and 9/24 (37.5%), respectively; p < 0.05). However, this is insufficient for differential diagnosis of these diseases.

1. Panteleev A.M., Nikulina O.V., Khristusev A.S., Dracheva M.S., Sokolova O.S., Zonova A.V. Differential diagnostics of tuberculosis and mycobacteriosis in HIV patients. Tuberculosis and Lung Diseases, 2017, vol. 95, no. 10, pp. 47-52. (In Russ.)

2. Regiony Rossii. Sotsialno-ekonomicheskiye pokazateli 2017. Statisticheskiy sbornik. [Regions of Russia. Socio-economic rates for 2017. Statistical collection]. Moscow, Rosstat Publ., 2017.

3. Detjen A.K., Keil T., Roll S. et al. Interferon-γ Release Assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin. Infect. Dis., 2007, vol. 45, no. 3, pp. 322-328.

4. Diel R., Jacob J., Lampenius N., et al. Burden of non-tuberculous mycobacterial pulmonary disease in Germany. Eur. Respir. J., 2017, vol. 49, no. 4, pp. 1602109 https://doi.org/10.1183/13993003.02109-2016

5. Griffith D.E., Aksamit T., Brown-Elliott B.A. et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med., 2007, vol. 175, no. 4, pp. 367-416. https://doi.org/10.1164/rccm.200604-571ST

6. Haworth C.S., Banks J., Capstick T. et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax, 2017, no. 72, suppl. 2, pp. – ii1-ii64. https://doi.org/10.1136/thoraxjnl-2017-210927

7. Hoefsloot W., Ingen J. van, Andrejak C. et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur. Respir. J., 2013, vol. 42, no. 6, pp. 1604-1613. https://doi.org/10.1183/09031936.00149212

8. Lee H.S., Wei Y.F., Tsai Y.J. et al. Prevalence of latent tuberculous infection in patients with nontuberculous mycobacterial lung disease and colonization: a prospective study in an intermediate tuberculosis burden country. Open Forum Infect. Dis., 2022, vol. 9, no. 3, pp. ofac072. https://doi.org/10.1093/ofid/ofac072

9. Strollo S.E., Adjemian J., Adjemian M.K., Prevots D.R. The burden of pulmonary nontuberculous mycobacterial disease in the United States. Ann Am. Thorac. Soc., 2015, vol. 12, no. 10, pp. 1458-1464. https://doi.org/10.1513/AnnalsATS.201503-173OC

10. Thomson R., Donnan E., Konstantinos A. Notification of nontuberculous mycobacteria: an Australian perspective. Ann Am. Thorac. Soc., 2017, vol. 14, no. 3, pp. 318-323. https://doi.org/10.1513/AnnalsATS.201612-994OI